Errors of commission or omission: The net risk safety analysis conversation we should be having around automated insulin delivery systems.
AID
APS
artificial pancreas
automated insulin delivery
closed loop
hybrid closed loop
risk analysis
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
02
09
2021
received:
27
05
2021
accepted:
07
08
2021
pubmed:
13
9
2021
medline:
20
4
2022
entrez:
12
9
2021
Statut:
ppublish
Résumé
The question of safety often arises when discussing automated insulin delivery systems, but discussion of safety is often anchored on a comparison to the risk to a person without diabetes, overlooking the risks of living with insulin-requiring diabetes. We should use a net risk safety perspective for evaluating diabetes technology that takes into account the ongoing risks of insulin management for people living with diabetes.
Substances chimiques
Blood Glucose
0
Hypoglycemic Agents
0
Insulin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14687Informations de copyright
© 2021 Diabetes UK.
Références
Senior P, Lam A, Farnsworth K, Perkins B, Rabasa-Lhoret R. Assessment of risks and benefits of beta cell replacement versus automated insulin delivery systems for type 1 diabetes. Curr DiabRep. 2020;20(10):1.
Heinemann L, Lange K. “Do It Yourself” (DIY)-Automated Insulin Delivery (AID) Systems: current status from a German point of view. J Diabetes Sci Technol. 2020;14(6):1028-1034. doi:10.1177/1932296819889641
Institute for Safe Medication Practices (ISMP). Guidelines for Optimizing Safe Subcutaneous Insulin Use in Adults. Institute for Safe Medication Practices. https://www.ismp.org/guidelines/subcutaneous-insulin. Published June 5, 2017. Accessed May 20, 2021.
Spiller HA, Borys DJ, Ryan ML, Sawyer TS, Wilson BL. Unintentional Therapeutic errors involving insulin in the ambulatory setting reported to poison centers. Ann Pharmacother. 2010;45(1):17-22. doi:10.1345/aph.1p517
Geller AI, Shehab N, Lovegrove MC, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med. 2014;174(5):678. doi:10.1001/jamainternmed.2014.136
NICE. Evidence context: safer insulin prescribing: advice. https://www.nice.org.uk/advice/ktt20/chapter/Evidence-context#safety-alerts. Accessed May 20, 2021.
Pennsylvania Patient Safety Authority. Focus on high-alert medications. Pa Patient Saf Advis. 2004;1(3):6. http://patientsafety.pa.gov/ADVISORIES/Pages/200409_06.aspx. Accessed May 20, 2021
Lewis D. History and perspective on DIY closed looping. J Diabetes Sci Technol. 2018;13(4):790-793. doi:10.1177/1932296818808307
Litchman ML, Lewis D, Kelly LA, Gee PM. Twitter analysis of #OpenAPS DIY artificial pancreas technology use suggests improved A1C and quality of life. J Diabetes Sci Technol. 2019;13(2):164-170. doi:10.1177/1932296818795705
Schütz-Fuhrmann I, Schütz AK, Eichner M, Mader JK. Two subsequent pregnancies in a woman with type 1 diabetes: artificial pancreas was a gamechanger. J Diabetes Sci Technol. 2020;14(5):972-973. doi:10.1177/1932296820906219
Wu Z, Luo S, Zheng X, et al. Use of a do-it-yourself artificial pancreas system is associated with better glucose management and higher quality of life among adults with type 1 diabetes. Ther Adv Endocrinol Metab. 2020;11:204201882095014. doi:10.1177/2042018820950146
Kalisch BJ, Landstrom G, Williams RA. Missed nursing care: errors of omission. Nurs Outlook. 2009;57(1):3-9.
Kennedy AG, MacLean CD. Clinical inertia: errors of omission in drug therapy. Am J Health Syst Pharm. 2004;61(4):401-404. doi:10.1093/ajhp/61.4.401
Asarani NAM, Reynolds AN, Elbalshy M, et al. Efficacy, safety, and user experience of DIY or open-source artificial pancreas systems: a systematic review. Acta Diabetol. 2020;58(5):539-547. doi:10.1007/s00592-020-01623-4
Roberts JTF, Moore V, Quigley M. Prescribing unapproved medical devices? The case of DIY artificial pancreas systems. Med Law Int. 2021;21(1):42-68. doi:10.1177/0968533221997510
Lum JW, Bailey RJ, Barnes-Lomen V, et al. A real-world prospective study of the safety and effectiveness of the loop open source automated insulin delivery system. Diabetes Technol Ther. 2021;23(5):367-375. doi:10.1089/dia.2020.0535
Jaser SS, Yates H, Dumser S, Whittemore R. Risky business: risk behaviors in adolescents with type 1 diabetes. Diabetes Educ. 2011;37(6):756-764. doi:10.1177/0145721711422610
Ambrus DB, O'Connor MJ. Things we do for no reason: sliding-scale insulin as monotherapy for glycemic control in hospitalized patients. J Hosp Med. 2019;14(2):114-116. doi:10.12788/jhm.3109